Jun 9, 2026 04:38PM
Jun 8, 2026 02:56AM
Jun 7, 2026 04:45PM
Jun 3, 2026 09:01AM
Jun 3, 2026 09:00AM
May 19, 2026 04:05PM
May 19, 2026 04:05PM AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH
May 13, 2026 08:30AM
May 11, 2026 08:30AM
May 4, 2026 09:01AM
May 4, 2026 09:00AM
Apr 30, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 22, 2026 04:00PM AMGEN announces CTO David Reese retirement and leadership changes
Apr 22, 2026 04:00PM
Apr 6, 2026 09:00AM
Apr 6, 2026 09:00AM
Apr 2, 2026 08:07AM
Mar 28, 2026 04:45PM
Mar 4, 2026 04:01PM
Feb 3, 2026 04:01PM AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
Jan 6, 2026 09:28AM
Jan 6, 2026 09:01AM
Jan 6, 2026 09:00AM
Dec 19, 2025 02:24PM
Dec 19, 2025 02:23PM
Dec 11, 2025 06:10PM
Dec 11, 2025 06:09PM FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Dec 9, 2025 04:01PM
Nov 25, 2025 05:07AM
Nov 19, 2025 04:02PM
Nov 19, 2025 04:01PM
Nov 8, 2025 10:15AM
Nov 8, 2025 10:15AM
Nov 4, 2025 04:01PM AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Oct 31, 2025 04:01PM
Oct 31, 2025 09:00AM
Oct 31, 2025 09:00AM
Oct 17, 2025 04:00PM
Oct 17, 2025 04:00PM
Oct 6, 2025 09:01AM
Oct 6, 2025 09:00AM AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Oct 6, 2025 09:00AM
Oct 2, 2025 09:00AM
Oct 2, 2025 09:00AM
Sep 26, 2025 09:00AM
Sep 26, 2025 09:00AM
Sep 9, 2025 12:13AM
Sep 9, 2025 12:12AM Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
Sep 8, 2025 08:04PM

1,158,072 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All